|
Coru Medical Systems ، Inc. (KRMD) DCF تقييم
US | Healthcare | Medical - Instruments & Supplies | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
KORU Medical Systems, Inc. (KRMD) Bundle
تقييم التوقعات المالية لشركة Koru Medical Systems ، Inc. كخبير! توفر لك حاسبة DCF (KRMD) هذه المالية المملوءة مسبقًا والمرونة الكاملة لتعديل نمو الإيرادات و WACC والهوامش وغيرها من الافتراضات الأساسية التي تتماشى مع توقعاتك.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 23.2 | 24.2 | 23.5 | 27.9 | 28.5 | 30.1 | 31.8 | 33.6 | 35.5 | 37.5 |
| Revenue Growth, % | 0 | 4.38 | -2.84 | 18.76 | 2.23 | 5.63 | 5.63 | 5.63 | 5.63 | 5.63 |
| EBITDA | 4.3 | 1.6 | -6.6 | -10.2 | -9.4 | -4.3 | -4.6 | -4.8 | -5.1 | -5.4 |
| EBITDA, % | 18.74 | 6.66 | -27.95 | -36.54 | -32.96 | -14.41 | -14.41 | -14.41 | -14.41 | -14.41 |
| Depreciation | .3 | .4 | .5 | .6 | .9 | .6 | .7 | .7 | .7 | .8 |
| Depreciation, % | 1.47 | 1.73 | 1.97 | 2.1 | 3.05 | 2.07 | 2.07 | 2.07 | 2.07 | 2.07 |
| EBIT | 4.0 | 1.2 | -7.0 | -10.8 | -10.3 | -5.0 | -5.2 | -5.5 | -5.8 | -6.2 |
| EBIT, % | 17.28 | 4.93 | -29.93 | -38.65 | -36.01 | -16.48 | -16.48 | -16.48 | -16.48 | -16.48 |
| Total Cash | 5.9 | 27.3 | 25.3 | 17.4 | 11.5 | 19.8 | 20.9 | 22.0 | 23.3 | 24.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 3.2 | 2.6 | 4.3 | 4.5 | 4.1 | 4.4 | 4.7 | 4.9 | 5.2 | 5.5 |
| Account Receivables, % | 13.96 | 10.64 | 18.35 | 16.24 | 14.29 | 14.7 | 14.7 | 14.7 | 14.7 | 14.7 |
| Inventories | 2.4 | 6.8 | 6.1 | 6.4 | 3.5 | 6.0 | 6.3 | 6.7 | 7.1 | 7.5 |
| Inventories, % | 10.31 | 28.25 | 26 | 22.96 | 12.21 | 19.94 | 19.94 | 19.94 | 19.94 | 19.94 |
| Accounts Payable | .6 | .6 | 1.2 | 2.4 | 1.0 | 1.3 | 1.4 | 1.5 | 1.6 | 1.7 |
| Accounts Payable, % | 2.47 | 2.58 | 5.23 | 8.57 | 3.42 | 4.46 | 4.46 | 4.46 | 4.46 | 4.46 |
| Capital Expenditure | -.4 | -1.1 | -.4 | -2.8 | -.8 | -1.2 | -1.3 | -1.4 | -1.5 | -1.6 |
| Capital Expenditure, % | -1.84 | -4.39 | -1.6 | -10.04 | -2.86 | -4.14 | -4.14 | -4.14 | -4.14 | -4.14 |
| Tax Rate, % | -40.59 | -40.59 | -40.59 | -40.59 | -40.59 | -40.59 | -40.59 | -40.59 | -40.59 | -40.59 |
| EBITAT | 3.2 | 1.2 | -5.0 | -8.7 | -14.4 | -4.3 | -4.5 | -4.8 | -5.1 | -5.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -1.9 | -3.2 | -5.4 | -10.3 | -12.4 | -7.4 | -5.7 | -6.0 | -6.4 | -6.7 |
| WACC, % | 6.07 | 6.09 | 6.06 | 6.07 | 6.09 | 6.08 | 6.08 | 6.08 | 6.08 | 6.08 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -27.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -7 | |||||||||
| Terminal Value | -169 | |||||||||
| Present Terminal Value | -126 | |||||||||
| Enterprise Value | -153 | |||||||||
| Net Debt | -7 | |||||||||
| Equity Value | -146 | |||||||||
| Diluted Shares Outstanding, MM | 46 | |||||||||
| Equity Value Per Share | -3.20 |
What You Will Receive
- Flexible Forecast Inputs: Modify key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: KORU Medical Systems, Inc.'s (KRMD) financial data pre-loaded to facilitate your analysis.
- Automated DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A refined Excel model tailored to meet your valuation requirements.
- Designed for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Comprehensive DCF Calculator: Features both unlevered and levered DCF valuation models tailored for KORU Medical Systems, Inc. (KRMD).
- WACC Calculator: A pre-configured Weighted Average Cost of Capital tool with adjustable parameters.
- Customizable Forecast Assumptions: Easily update growth projections, capital expenditures, and discount rates.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to KORU Medical Systems, Inc. (KRMD).
- Interactive Dashboard and Charts: Visual representations that encapsulate essential valuation metrics for straightforward analysis.
How It Works
- Download the Template: Gain immediate access to the Excel-based KORU Medical Systems DCF Calculator for (KRMD).
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates KORU Medical Systems' intrinsic value.
- Test Scenarios: Experiment with different assumptions to assess potential valuation shifts.
- Analyze and Decide: Utilize the results to inform your investment or financial decisions.
Why Choose This Calculator for KORU Medical Systems, Inc. (KRMD)?
- Accurate Data: Utilize real KORU Medical financials for dependable valuation outcomes.
- Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
- Time-Saving: Pre-configured calculations save you the hassle of starting from the ground up.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the medical sector.
- User-Friendly: Clear layout and guided instructions make it accessible for all users.
Who Should Use KORU Medical Systems, Inc. (KRMD)?
- Healthcare Providers: Enhance patient care with innovative medical delivery systems.
- Investors: Analyze growth potential with cutting-edge medical technology insights.
- Medical Professionals: Streamline procedures using advanced and reliable medical devices.
- Researchers: Explore new applications and improvements in medical delivery systems.
- Educators and Students: Utilize KORU's solutions as case studies in healthcare technology courses.
What the Template Contains
- Preloaded KRMD Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.